Safety of Riociguat in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension with Concomitant Novel Oral Anticoagulants or Vitamin K Antagonist Use: Data from the EXPERT Registry

Humbert, M.; Simonneau, G.; Pittrow, D.; Delcroix, M.; Pepke-Zaba, J.; Langleben, D.; Mielniczuk, L. M.; Escribano-Subias, P.; Klotsche, J.; Meier, C.; Hoeper, M. M.

Published in

C104. LATEST CLINICAL INVESTIGATIONS IN ACUTE AND CHRONIC THROMBOEMBOLISM DISORDERS OF THE PULMONARY CIRCULATION, 2020

DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6043

Tools

Export citation

Search in Google Scholar

Safety of Riociguat in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension with Concomitant Novel Oral Anticoagulants or Vitamin K Antagonist Use: Data from the EXPERT Registry

Journal article published in 2020 by M. Humbert, G. Simonneau, D. Pittrow, M. Delcroix, J. Pepke-Zaba, D. Langleben, L. M. Mielniczuk, P. Escribano-Subias

, J. Klotsche, C. Meier, M. M. Hoeper

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Safety of Riociguat in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension with Concomitant Novel Oral Anticoagulants or Vitamin K Antagonist Use: Data from the EXPERT Registry